Experts advocate holistic Semaglutide use as therapy goes off patent in India
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings
New facility in Sector 51 offers advanced, affordable, and patient-centric dialysis services for NCR patients
As part of the deal, Red Nucleus also gains indirect ownership of the company’s Indian arm
Move aligns global biologics identity under the Biocon Biologics brand
Safety was equally impressive. ENV-294 was well tolerated
In his new role, Saran will spearhead the end-to-end launch framework for innovation-led portfolio
With more than two decades of experience, he brings deep expertise in sales, marketing, business transformation, and strategic leadership
Board approves five-year appointment, subject to shareholder nod through postal ballot
Paid-up equity capital rises to Rs 973.19 crore following allotment to eligible employees
Subscribe To Our Newsletter & Stay Updated